The relationship between leadership style and health worker motivation, job satisfaction and teamwork in Uganda by Musinguzi C, Namale L, Rutebemberwa E, Dahal A, Nahirya-Ntege P, Kekitiinwa A

Get full text

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis by Prendergast, A, Bwakura-Dangarembizi, M, Mugyenyi, P, Lutaakome, J, Kekitiinwa, A, Thomason, M, Gibb, D, Walker, A

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children by Kekitiinwa, A, Musiime, V, Thomason, M, Mirembe, G, Lallement, M, Nakalanzi, S, Baptiste, D, Walker, A, Gibb, D, Judd, A

Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. by Kekitiinwa, A, Lee, K, Walker, A, Maganda, A, Doerholt, K, Kitaka, S, Asiimwe, A, Judd, A, Musoke, P, Gibb, D

Pubertal development in HIV-infected African children on first-line antiretroviral therapy. by Szubert, A, Musiime, V, Bwakura-Dangarembizi, M, Nahirya-Ntege, P, Kekitiinwa, A, Gibb, D, Nathoo, K, Prendergast, A, Walker, A

Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children by Kekitiinwa, A, Szubert, A, Spyer, M, Katuramu, R, Musiime, V, Mhute, T, Bakeera–Kitaka, S, Senfuma, O, Mujoma, M, Walker, A, Gibb, D

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children by Kekitiinwa, A, Szubert, A, Spyer, M, Katuramu, R, Musiime, V, Mhute, T, Bakeera-Kitaka, S, Senfuma, O, Walker, A, Gibb, D, ARROW Trial Team

The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children. by Musiime, V, Fillekes, Q, Kekitiinwa, A, Kendall, L, Keishanyu, R, Namuddu, R, Young, N, Opilo, W, Lallemant, M, Walker, A, Burger, D, Gibb, D

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. by Walker, A, Prendergast, A, Mugyenyi, P, Munderi, P, Hakim, J, Kekitiinwa, A, Katabira, E, Gilks, C, Kityo, C, Nahirya-Ntege, P, Nathoo, K, Gibb, D

The effect of diurnal variation, CYP2B6 genotype, and age on the pharmacokinetics of nevirapine in African Children by Bienczak, A, Cook, A, Wiesner, L, Mulenga, V, Kityo, C, Kekitiinwa, A, Walker, A, Owen, A, Gibb, D, Burger, D, McIlleron, H, Denti, P

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study. by Picat, M, Lewis, J, Musiime, V, Prendergast, A, Nathoo, K, Kekitiinwa, A, Nahirya Ntege, P, Gibb, D, Thiebaut, R, Walker, A, Klein, N, Callard, R

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1. by Kasirye, P, Kendall, L, Adkison, K, Tumusiime, C, Ssenyonga, M, Bakeera-Kitaka, S, Nahirya-Ntege, P, Mhute, T, Kekitiinwa, A, Snowden, W, Burger, D, Gibb, D, Walker, A

Improved adherence to antiretroviral therapy observed among HIV-infected children whose caregivers had positive beliefs in medicine in Sub-Saharan Africa by Abongomera, G, Cook, A, Musiime, V, Chabala, C, Lamorde, M, Abach, J, Thomason, M, Mulenga, V, Kekitiinwa, A, Colebunders, R, Kityo, C, Walker, A, Gibb, D

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial. by Musiime, V, Kendall, L, Bakeera-Kitaka, S, Snowden, W, Odongo, F, Thomason, M, Musoke, P, Adkison, K, Burger, D, Mugyenyi, P, Kekitiinwa, A, Gibb, D, Walker, A

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children by Bienczak, A, Cook, A, Wiesner, L, Olagunju, A, Mulenga, V, Kityo, C, Kekitiinwa, A, Owen, A, Walker, A, Gibb, D, McIlleron, H, Burger, D, Denti, P

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy. by Bwakura-Dangarembizi, M, Musiime, V, Szubert, A, Prendergast, A, Gomo, Z, Thomason, M, Musarurwa, C, Mugyenyi, P, Nahirya, P, Kekitiinwa, A, Gibb, D, Walker, A, Nathoo, K

Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children. by Bienczak, A, Denti, P, Cook, A, Wiesner, L, Mulenga, V, Kityo, C, Kekitiinwa, A, Gibb, D, Burger, D, Walker, A, McIlleron, H, Chirehwa, M, Owen, A

Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe by Prendergast, A, Berejena, C, Pimundu, G, Shonhai, A, Bwakura-Dangarembizi, M, Musiime, V, Szubert, A, Cook, A, Spyer, M, Nahirya-Ntege, P, Kekitiinwa, A, Gibb, D, Klein, N, Walker, A

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. by Bwakura-Dangarembizi, M, Kendall, L, Bakeera-Kitaka, S, Nahirya-Ntege, P, Keishanyu, R, Nathoo, K, Spyer, M, Kekitiinwa, A, Lutaakome, J, Mhute, T, Kasirye, P, Munderi, P, Musiime, V, Gibb, D, Walker, A, Prendergast, A

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. by Crook, A, Turkova, A, Musiime, V, Bwakura-Dangarembizi, M, Bakeera-Kitaka, S, Nahirya-Ntege, P, Thomason, M, Mugyenyi, P, Musoke, P, Kekitiinwa, A, Munderi, P, Nathoo, K, Prendergast, A, Walker, A, Gibb, D, ARROW Trial Team